Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF July 15, 2016 | Archived Issues

Meetings and Events

Physician Efficiency Training
July 20

Transcranial Doppler for Comprehensive Stroke Care
Aug. 11-13

Pancreatic Cancer Conference
Sept. 10

These events and more are listed in the medical staff calendar on the Cedars-Sinai website.


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - July 2016 (PDF)


Milestones

Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue. Click here to submit your milestones and comments.

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Core Labs Practice Changed for Urine Hemosiderin

Due to low volume, the Core laboratories in the Department of Pathology and Laboratory Medicine have begun sending out urine hemosiderin to ARUP laboratories. The change was made July 1.

Urine hemosiderin is sometimes ordered to detect hemosiderinuria, secondary to excess hemolysis, as with incompatible blood transfusions, severe acute hemolytic anemia, or hemochromatosis. However, it is not a front-line test for these purposes.

Other assessment like visible plasma and/or urine hemoglobin, or direct antiglobulin (Coombs) testing after a transfusion can be used to pick up incompatible transfusions.

For acute hemolytic anemia, the lab workup can include a complete blood cell count, peripheral blood smear, lactate dehydrogenase, haptoglobin, and indirect bilirubin.

After diagnosis, hemochromatosis can be assessed by evaluating serum transferrin saturation. The methodology will not change; urine hemosiderin will be continued to be performed by microscopy via the reference laboratory.

With any questions regarding this change, please contact Kimia Sobhani at kimia.sobhani@cshs.org or Holli Mason at holli.mason@cshs.org.